SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-20-010374
Filing Date
2020-08-12
Accepted
2020-08-12 07:05:48
Documents
46
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q mist-20200630x10q.htm 10-Q 1579140
2 EX-31.1 mist-20200630ex311de53b8.htm EX-31.1 11762
3 EX-31.2 mist-20200630ex312ea0ed3.htm EX-31.2 11754
4 EX-32.1 mist-20200630ex32172ee5d.htm EX-32.1 9399
  Complete submission text file 0001558370-20-010374.txt   4918589

Data Files

Seq Description Document Type Size
5 EX-101.INS mist-20200630.xml EX-101.INS 1056873
6 EX-101.SCH mist-20200630.xsd EX-101.SCH 27220
7 EX-101.CAL mist-20200630_cal.xml EX-101.CAL 27329
8 EX-101.DEF mist-20200630_def.xml EX-101.DEF 108144
9 EX-101.LAB mist-20200630_lab.xml EX-101.LAB 272472
10 EX-101.PRE mist-20200630_pre.xml EX-101.PRE 206301
Mailing Address 1111 DR. FREDERIK-PHILIPS BLVD SUITE 420 MONTREAL A8 H4M 2X6
Business Address 1111 DR. FREDERIK-PHILIPS BLVD SUITE 420 MONTREAL A8 H4M 2X6 (514) 336-0444
Milestone Pharmaceuticals Inc. (Filer) CIK: 0001408443 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38899 | Film No.: 201094063
SIC: 2834 Pharmaceutical Preparations